Skip to main content
Lasa Supergenerics Limited logo

Lasa Supergenerics Limited — Investor Relations & Filings

Ticker · LASA ISIN · INE670X01014 LEI · 984500B9EA5EC3R2F726 BSE.NS Manufacturing
Open in API
Filings indexed 453 across all filing types
Latest filing 2025-08-01 Board/Management Inform…
Country IN India
Listing BSE.NS LASA

About Lasa Supergenerics Limited

https://lasalabs.com/

Lasa Supergenerics Limited is a vertically integrated manufacturer specializing in Active Pharmaceutical Ingredients (APIs) for both veterinary and human health applications. The company focuses on the research, development, and production of high-quality chemical intermediates and APIs. Its core product portfolio includes a significant range of anthelmintics, such as Albendazole, Fenbendazole, and Ricobendazole, alongside other specialized therapeutic categories. Utilizing advanced manufacturing facilities and a dedicated research and development wing, the organization emphasizes cost-effective production processes and stringent quality control standards. Lasa Supergenerics Limited serves a global clientele, providing essential components for pharmaceutical formulations and animal health products through its expertise in complex chemical synthesis and large-scale manufacturing capabilities.

Recent filings

Filing Released Lang Actions
Shareholders meeting
Board/Management Information Classification · 95% confidence The document is a detailed notice of a Postal Ballot seeking shareholder approval for the appointment of an Executive Director. It includes references to the Companies Act, SEBI Listing Regulations, and procedural details about remote e-voting, cut-off dates, and scrutinizer appointment. The content focuses on governance matters, specifically board/management changes, and the resolution to appoint a new executive director. There are no financial statements or earnings data, nor is this a report or announcement of financial results. It is not a proxy solicitation or voting results declaration but the notice for voting itself. Therefore, the document fits best under Board/Management Information (MANG), as it announces a proposed change in senior management requiring shareholder approval.
2025-08-01 English
Resignation of Independent director
Regulatory Filings
2025-08-01 English
Resignation
Board/Management Information Classification · 100% confidence The document is a formal communication addressed to stock exchanges (BSE and NSE) regarding the resignation of an Independent Director, Ms. Manali Bhagtani, from LASA Supergenerics Limited. It references compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosures about changes in the board or management. The content includes the resignation letter, reasons for resignation, and other related details. There are no financial statements, earnings data, or report publications. The document is clearly an announcement of a change in the company's board of directors, not a full report or financial filing. Therefore, the appropriate classification is Board/Management Information (MANG).
2025-08-01 English
Resignation
Board/Management Information Classification · 100% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding the resignation of an Independent Director, Mr. Hardesh Tolani, from LASA Supergenerics Limited. It references compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events including changes in directors. The document includes the resignation letter and detailed reasons for resignation, confirming no other material reasons exist. There are no financial statements or performance data, nor is this an announcement of a report publication. The content clearly fits the category of Board/Management Information (MANG), as it announces a change in the company's board of directors.
2025-08-01 English
Resignation of Independent director
Regulatory Filings
2025-07-31 English
Resignation
Board/Management Information Classification · 100% confidence The document is a formal communication addressed to stock exchanges (BSE and NSE) regarding the resignation of an Independent Director, Ms. Manali Bhagtani, from LASA Supergenerics Limited. It references compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events including changes in board composition. The document includes the resignation letter and details about the resignation, but does not contain financial data, audit information, or any report content. It is clearly an announcement of a change in the company's board of directors, not a financial report or other filing type. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is about 4856 characters, which is consistent with a detailed announcement rather than a full report.
2025-07-31 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.